Soleno Therapeutics, Inc. (SLNO)
Total Valuation
SLNO has a market cap or net worth of $1.39 billion. The enterprise value is $1.22 billion.
Market Cap | 1.39B |
Enterprise Value | 1.22B |
Important Dates
The last earnings date was Wednesday, March 6, 2024, before market open.
Earnings Date | Mar 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SLNO has 32.46 million shares outstanding. The number of shares has increased by 96.40% in one year.
Shares Outstanding | 32.46M |
Shares Change (YoY) | +96.40% |
Shares Change (QoQ) | +44.20% |
Owned by Insiders (%) | 2.15% |
Owned by Institutions (%) | 97.15% |
Float | 13.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 8.83 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.89, with a Debt / Equity ratio of 0.00.
Current Ratio | 14.89 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -79.70% and return on invested capital (ROIC) is -24.49%.
Return on Equity (ROE) | -79.70% |
Return on Assets (ROA) | -52.90% |
Return on Capital (ROIC) | -24.49% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.18M |
Employee Count | 33 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,764.13% in the last 52 weeks. The beta is -1.52, so SLNO's price volatility has been lower than the market average.
Beta (1Y) | -1.52 |
52-Week Price Change | +1,764.13% |
50-Day Moving Average | 46.28 |
200-Day Moving Average | 24.97 |
Relative Strength Index (RSI) | 43.23 |
Average Volume (30 Days) | 302,093 |
Short Selling Information
The latest short interest is 2.30 million, so 7.10% of the outstanding shares have been sold short.
Short Interest | 2.30M |
Short Previous Month | 1.68M |
Short % of Shares Out | 7.10% |
Short % of Float | 17.44% |
Short Ratio (days to cover) | 7.51 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -38.67M |
Pretax Income | -38.99M |
Net Income | -38.99M |
EBITDA | -36.71M |
EBIT | -38.99M |
Earnings Per Share (EPS) | -$2.36 |
Balance Sheet
The company has $169.68 million in cash and $403,000 in debt, giving a net cash position of $169.28 million or $5.21 per share.
Cash & Cash Equivalents | 169.68M |
Total Debt | 403,000 |
Net Cash | 169.28M |
Net Cash Per Share | $5.21 |
Equity / Book Value | 157.51M |
Book Value Per Share | 4.85 |
Working Capital | 159.85M |
Cash Flow
Operating Cash Flow | -24.94M |
Capital Expenditures | n/a |
Free Cash Flow | -24.94M |
FCF Per Share | -$1.51 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SLNO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -96.40% |
Shareholder Yield | -96.40% |
Earnings Yield | -2.80% |
FCF Yield | -1.79% |
Analyst Forecast
The average price target for SLNO is $55.60, which is 29.47% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $55.60 |
Price Target Difference | 29.47% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.
Last Split Date | Aug 26, 2022 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |